Modelling the recurrence of bladder cancer

被引:2
|
作者
Santamaria, C. [1 ]
Garcia-Mora, B. [1 ]
Rubio, G. [1 ]
Pontones, J. L. [2 ]
机构
[1] Univ Politecn Valencia, Inst Matemat Multidisciplinar, E-46071 Valencia, Spain
[2] Hosp Univ La Fe, Valencia, Spain
关键词
bladder carcinoma; prognostic factors; recurrence; interval-censored survival data; generalized non-linear model;
D O I
10.1007/s10440-008-9242-2
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
The risk of a new tumor recurrence after transurethral resection (surgical operation) in patients with primary superficial bladder carcinoma is evaluated. As the exact time of the event is not known, it is suggested to consider interval-censored survival data methodology. We use the model of Farrington to perform a prognostic model for predicting a new recurrence and to determine the clinicopathologic factors associated within interval-censored data framework. The implementation of this method is easy using standard statistical packages. Anyway, we use diagnostic methods for the validation of the model developed by the same author for interval-censored data. The obtained model is easily interpretable and let us to individualize the course of follow-up and treatment of each patient in order to improve the patient's quality of life.
引用
收藏
页码:91 / 105
页数:15
相关论文
共 50 条
  • [31] BLADDER-CANCER - PATTERN OF RECURRENCE IN 142 PATIENTS
    TIMMER, PR
    HARTLIEF, HA
    HOOIJKAAS, JAP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (05): : 899 - 905
  • [33] Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle
    Fankhauser, Christian D.
    Mostafid, Hugh
    CURRENT OPINION IN UROLOGY, 2018, 28 (01) : 88 - 92
  • [34] ANDROGEN DEPRIVATION THERAPY PREVENTS RECURRENCE OF BLADDER CANCER
    Izumi, Koji
    Taguri, Mastaka
    Miyamoto, Hiroshi
    Ito, Yusuke
    Miyoshi, Yasuhide
    Moriyama, Masatoshi
    Murai, Tetsuo
    Hayashi, Hiroyuki
    Inayama, Yoshiaki
    Nagashima, Yoji
    Morita, Satoshi
    Uemura, Hiroji
    JOURNAL OF UROLOGY, 2015, 193 (04): : E536 - E536
  • [35] The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence
    Gu, J
    Grossman, HB
    Dinng, CP
    Wu, XF
    PHARMACOGENOMICS, 2005, 6 (06) : 575 - 584
  • [36] VAGINAL RECURRENCE AFTER CYSTECTOMY FOR BLADDER-CANCER
    CHIN, JL
    WOLF, RM
    HUBEN, RP
    PONTES, JE
    JOURNAL OF UROLOGY, 1985, 134 (01): : 58 - 61
  • [37] Bladder cancer recurrence surveillance by urine metabolomics analysis
    Loras, A.
    Trassierra, M.
    Sanjuan-Herraez, D.
    Martinez-Bisbal, M. C.
    Castell, J. V.
    Quintas, G.
    Ruiz-Cerda, J. L.
    SCIENTIFIC REPORTS, 2018, 8
  • [38] Prevention of bladder cancer incidence and recurrence: tobacco use
    Soria, Francesco
    Marra, Giancarlo
    Capoun, Otakar
    Soukup, Viktor
    Gontero, Paolo
    CURRENT OPINION IN UROLOGY, 2018, 28 (01) : 80 - 87
  • [39] Nomograms for bladder cancer recurrence according to grade and stage
    Shariat, SF
    Zippe, CD
    Friedrich, MG
    Lüdecke, G
    Sanchez-Carbayo, M
    Casella, R
    Mian, C
    Sawczuk, IS
    Eissa, S
    Akaza, H
    Serretta, V
    Huland, H
    Wians, F
    Rupesh, R
    Miyanaga, N
    Sagalowsky, AI
    Lotan, Y
    Perrotte, P
    Marberger, M
    Karakiewicz, PI
    JOURNAL OF UROLOGY, 2004, 171 (04): : 69 - 69
  • [40] FACTORS INFLUENCING THE RECURRENCE RATE OF BLADDER-CANCER
    LOENING, S
    NARAYANA, A
    YODER, L
    SLYMEN, D
    WEINSTEIN, S
    PENICK, G
    CULP, D
    JOURNAL OF UROLOGY, 1980, 123 (01): : 29 - 31